[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,310,900
  • Shares Outstanding, K 145,056
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,941 M
  • EBITDA $ 2,177 M
  • 60-Month Beta 0.78
  • Price/Sales 5.67
  • Price/Cash Flow 18.13
  • Price/Book 4.54

Options Overview Details

View History
  • Implied Volatility 43.76% (+0.51%)
  • Historical Volatility 40.12%
  • IV Percentile 98%
  • IV Rank 73.54%
  • IV High 52.18% on 10/30/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 22) 16.83 (7.85%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 2,856
  • Volume Avg (30-Day) 1,302
  • Put/Call OI Ratio 1.45
  • Today's Open Interest 15,577
  • Open Int (30-Day) 16,179
  • Expected Range 197.46 to 231.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.90
  • Number of Estimates 5
  • High Estimate $2.95
  • Low Estimate $2.86
  • Prior Year $2.55
  • Growth Rate Est. (year over year) +13.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
190.21 +12.66%
on 07/23/26
222.43 -3.66%
on 07/06/26
+15.86 (+7.99%)
since 06/29/26
3-Month
180.26 +18.87%
on 06/02/26
222.43 -3.66%
on 07/06/26
+2.36 (+1.11%)
since 04/29/26
52-Week
180.26 +18.87%
on 06/02/26
293.81 -27.07%
on 08/22/25
-63.41 (-22.83%)
since 07/29/25

Most Recent Stories

More News
3 Cash-Heavy Stocks to Research Further

3 Cash-Heavy Stocks to Research Further

MYRG : 322.06 (-5.48%)
RMD : 214.29 (+2.55%)
ABNB : 153.01 (-0.07%)
BetterInvestingâ„¢ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)

TROY, Mich. , July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc. (NYSE:...

BR : 159.20 (+0.64%)
RMD : 214.29 (+2.55%)
2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore

2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore

RMD : 214.29 (+2.55%)
SNEX : 72.07 (-2.98%)
USFD : 102.35 (+0.87%)
ResMed's Q4 2026 Earnings: What to Expect

ResMed is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth.

ABT : 108.00 (+0.68%)
XLV : 166.24 (-0.61%)
$SPX : 7,316.15 (-1.52%)
RMD : 214.29 (+2.55%)
Resmed Announces Agreement to Sell MatrixCare Business

SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has entered...

RMD.AX : 30.250 (+0.87%)
RMD : 214.29 (+2.55%)
Why ResMed (RMD) Stock Is Trading Up Today

Why ResMed (RMD) Stock Is Trading Up Today

RMD : 214.29 (+2.55%)
Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026

SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday,...

RMD.AX : 30.250 (+0.87%)
RMD : 214.29 (+2.55%)
1 Oversold Stock Primed to Rebound and 2 We Find Risky

1 Oversold Stock Primed to Rebound and 2 We Find Risky

ENOV : 30.26 (+2.51%)
RMD : 214.29 (+2.55%)
AGO : 84.33 (-1.35%)
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos

MDLZ : 64.99 (+4.02%)
NU : 14.04 (-4.36%)
RMD : 214.29 (+2.55%)
SONO : 17.52 (+4.29%)
OCUL : 8.36 (-1.07%)
Stocks Retreat as Fed Signals Possible Higher Interest Rates

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.99%. June...

GOOGL : 336.71 (+0.90%)
AAPL : 338.19 (-0.56%)
FDXF : 144.36 (-4.39%)
TSLA : 298.32 (-2.97%)
AMD : 429.56 (-5.51%)
CME : 265.44 (+2.09%)
SPY : 729.46 (-1.54%)
META : 585.61 (-1.31%)
ADSK : 245.25 (+3.32%)
MU : 739.00 (-9.94%)
ORCL : 117.74 (-1.85%)
QQQ : 661.73 (-2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 224.48
2nd Resistance Point 219.84
1st Resistance Point 217.06
Last Price 214.29
1st Support Level 209.65
2nd Support Level 205.01
3rd Support Level 202.24

See More

52-Week High 293.81
Fibonacci 61.8% 250.44
Fibonacci 50% 237.04
Fibonacci 38.2% 223.64
Last Price 214.29
52-Week Low 180.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.